Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma

著录项

• 来源
  《Clinical lung cancer》 |2017年第3期|共3页
• 作者

  Genestreti Giovenzio; de Biase Dario; Di Battista Monica; Cavallo Giovanna; Degli Esposti Roberta; Visani Michela; Acquaviva Giorgia; Brand Thomas; Pession Annalisa; Tallini Giovanni; Brandes Alba A.;

  展开▼
• 作者单位

  Bellaria Hosp AUSL Bologna IRCCS Inst Neurol Sci Dept Med Oncol Bologna Italy;

  Univ Bologna Dept Pharm &

  Biotechnol FaBiT Bologna Italy;

  Bellaria Hosp AUSL Bologna IRCCS Inst Neurol Sci Dept Med Oncol Bologna Italy;

  Bellaria Hosp AUSL Bologna IRCCS Inst Neurol Sci Dept Med Oncol Bologna Italy;

  Bellaria Hosp AUSL Bologna IRCCS Inst Neurol Sci Dept Med Oncol Bologna Italy;

  Univ Bologna Sch Med AUSL Bologna Dept Med DIMES Mol Diagnost Unit Bologna Italy;

  Univ Bologna Sch Med AUSL Bologna Dept Med DIMES Mol Diagnost Unit Bologna Italy;

  Univ Bologna Dept Pharm &

  Biotechnol FaBiT Bologna Italy;

  Univ Bologna Dept Pharm &

  Biotechnol FaBiT Bologna Italy;

  Univ Bologna Sch Med AUSL Bologna Dept Med DIMES Mol Diagnost Unit Bologna Italy;

  Bellaria Hosp AUSL Bologna IRCCS Inst Neurol Sci Dept Med Oncol Bologna Italy;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词

  EGFR; Next generation sequencing; NSCLC; Tyrosine kinase inhibitors; Uncommon mutation;

  机译：EGFR;下一代测序;NSCLC;酪氨酸激酶抑制剂;罕见的突变;